Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: RE: I`m not even going to read this BS

RE: I`m not even going to read this BS

posted on Apr 08, 2006 06:13AM
B-Lunist - It might be easier to move 80 million shares 1 point than 400 million but you lose the liquidity factor. Less shares make it more difficult for you to sell and get the price you want as there are fewer shares available.

FWIW... which isn`t much.

Share
New Message
Please login to post a reply